Skip to main content
Fig. 3 | Breast Cancer Research

Fig. 3

From: The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy

Fig. 3

Predictive value of baseline DTCs. Bar chart showing pCR rate after NACT ± denosumab among the total cohort and the different subtypes of breast cancer with regard to DTC-status at baseline. P values according to the Fisher's Exact Test are indicated. HR: hormone receptor; HER2: human epidermal growth receptor 2; TNBC: triple-negative breast cancer

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us